Core Viewpoint - The stock price of *ST and Ke (002816) experienced an abnormal fluctuation with a cumulative increase of over 12% over two consecutive trading days on October 12 and 13, 2025, prompting a review by the company's board of directors [1] Group 1: Stock Performance - The company reported that there were no changes or supplements to previously disclosed information, and no undisclosed significant information affecting the stock price was found in public media [1] - The company's production and operations are reported to be normal, and there were no stock trading activities by the controlling shareholder or actual controller during the period of abnormal fluctuation [1] Group 2: Risk Warning - Due to failing to meet relevant indicators for the year 2024, the company's stock will be subject to delisting risk warning starting from April 30, 2025 [1] - The company continued to incur losses in the first half of 2025, and if it triggers relevant conditions in 2025, the stock will be terminated from listing [1]

Core Viewpoint - Shenzhen Yushun Electronics Co., Ltd. has experienced significant stock price fluctuations, with a cumulative decline exceeding 12% over three consecutive trading days, indicating abnormal volatility [1] Group 1: Stock Performance - The stock of *ST Yushun (002289) has seen a cumulative closing price drop of over 12% on September 29, 30, and October 9, which is classified as abnormal volatility [1] - The company has been under delisting risk warning since May 6 due to poor performance indicators, including net profit for the fiscal year 2024 [1] Group 2: Corporate Actions - The company is undergoing a major asset restructuring, which has been approved by the shareholders' meeting [1] - There are multiple risks associated with the restructuring, including challenges in fundraising and potential goodwill impairment [1] Group 3: Investor Advisory - The company advises investors to rely on information from designated media and to invest rationally [1]

Core Viewpoint - The stock of Tongling Nonferrous Metals Group has experienced an abnormal fluctuation, with a cumulative price deviation of +20% over three consecutive trading days from September 29 to October 9, 2025 [1] Company Operations - The company has confirmed that its production and operations are normal, and there have been no significant changes in the internal and external operating environment [1] - The company has conducted a self-examination and verified with its controlling shareholder regarding the operational status [1] Market Conditions - The company has issued a reminder to investors to be aware of market risks, particularly the uncertainty in product market prices [1]

Core Insights - ST Jinggu's stock price has experienced a significant decline, with a cumulative drop of over 12% in closing prices over three consecutive trading days, triggering an abnormal fluctuation standard [1] - The company is planning to donate 51% equity of Boda Digital Technology and transfer 51% equity of Huiyin Wood Industry, but both actions face uncertainties [1] - In the first half of 2025, the company's revenue decreased by 45.03%, resulting in a net loss exceeding 120 million yuan [1] - Huiyin Wood Industry has ceased operations due to asset preservation issues, involving 31 civil loan preservation and litigation cases, with a total amount of approximately 212 million yuan [1] - The company also faces around 19 million yuan in inventory losses and risks related to the management of the assets to be donated and declining performance [1]

Core Viewpoint - The company, Pingming Technology (688109.SH), has issued a risk warning announcement indicating that there has been no significant change in its fundamentals, but the stock price may be deviating from its current fundamentals [1] Group 1 - The company warns that if abnormal trading continues, it may apply for a trading suspension for verification according to relevant rules [1] - The company's stock may be subject to key monitoring by the Shanghai Stock Exchange due to unusual trading activities [1] - Investor accounts related to abnormal trading may face trading suspensions [1]

Group 1 - The company announced that its stock price has deviated by more than 30% over three consecutive trading days, indicating abnormal stock fluctuations [1] - After verification, the company found no need to correct or supplement previously disclosed information, and there have been no significant changes in its production operations or external business environment [1] - During the period of abnormal stock fluctuations, there were no stock trading activities by the controlling shareholder or actual controller [1]

Core Viewpoint - Nanjing Port's stock price experienced a significant fluctuation, with a cumulative increase exceeding 20% over two consecutive trading days, prompting a notice regarding abnormal trading behavior [1] Company Summary - The company's fundamental operations have not undergone any significant changes recently, and all production and business activities are functioning normally [1] - There have been no major adjustments in the market environment or industry policies affecting the company [1] Market Summary - The recent sharp increase in the company's stock price indicates potential risks, and investors are advised to be cautious in their trading decisions [1]

Core Viewpoint - 博瑞医药's stock has experienced a significant decline, with a cumulative drop of 70% over the last 30 trading days, indicating severe abnormal trading fluctuations [1] Company Summary - As of September 24, 博瑞医药's closing price was 72.5 yuan per share [1] - The latest rolling price-to-earnings (P/E) ratio for 博瑞医药 is 313.01, which is substantially higher than the average rolling P/E ratio of 31.43 for the pharmaceutical manufacturing industry over the past month [1] - 博瑞医药 has conducted a self-inspection and reported that its daily operations are normal, with no significant changes or fluctuations in production costs and sales [1] Industry Summary - The pharmaceutical manufacturing industry has an average rolling P/E ratio of 31.43, highlighting 博瑞医药's significantly elevated valuation compared to its peers [1]

Core Viewpoint - Hunan Kaimete Gas Co., Ltd. experienced a stock price fluctuation exceeding 20%, which is classified as an abnormal volatility situation, but the company confirmed that there are no undisclosed significant matters affecting the stock price [1] Group 1 - The company's stock price closed with a cumulative increase of over 20% on September 22-23, 2025, indicating abnormal market activity [1] - The company conducted a self-examination and verification, finding no corrections or supplements to previously disclosed information [1] - There were no significant changes in the internal and external environment affecting the company's operations, and the controlling shareholder and actual controller did not engage in any stock trading during the abnormal fluctuation period [1]

Group 1 - The stock of Tianpu Co., Ltd. (605255) has hit the daily limit up for 13 consecutive trading days, with a cumulative increase of 245%, reaching a price of 91.96 yuan per share [1] - The company has issued a warning regarding the significant short-term price increase, indicating a serious deviation from the company's fundamentals and potential for rapid decline [1] - Tianpu's main products include polymer fluid pipeline systems and sealing system components for traditional fuel vehicle manufacturing, with no major changes in its core business [1] Group 2 - The Shanghai Stock Exchange has noted abnormal fluctuations in Tianpu's stock and has issued multiple risk warning announcements, urging investors to exercise caution [2] - Some investors have engaged in trading behaviors that disrupt normal market order and mislead other investors, leading to self-regulatory measures such as account trading suspensions [2] - The exchange has reiterated the importance of risk awareness and compliance in trading activities [2]